<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940524-2-00041</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=84 g=1 f=1 --> Program Requirements <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In conducting activities to achieve the purpose of this program, the recipient will be responsible for the activities under A. (Recipient Activities), and CDC will be responsible for the activities listed under B. (CDC Activities). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Recipient Activities <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Recipients of funds under Part I are expected to support and enhance, and recipients under Part II are expected to plan, implement, and support the operation of population-based, statewide cancer registries in order to collect data concerning each form of invasive cancer with the exception of basal cell and squamous cell carcinoma of the skin and each form of in-situ cancer except for carcinoma in-situ of the cervix uteri. Data on carcinoma in-situ of the cervix uteri is not being collected at this time because it has been well documented that routine collection of such data is incomplete due to inconsistent collection of other High Grade Neoplasia. In addition, these data are not comparable over time because of changing terminology and diagnostic criteria. (Working Group on Pre-Invasive Cervical Neoplasia and Population-Based Cancer Registries Final Subcommittee Report, April 1993.) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Data to be collected for invasive and in-situ cancers include: <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=16 g=1 f=1 --> 1. Demographic information about each case of cancer including at a minimum: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=14 g=1 f=1 --> (a) Last name, first name, middle initial. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Address at diagnosis, including city, county, State, and zip code (or zip + 4 where available). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c) Census tract. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (d) Race and Spanish/Hispanic origin. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (e) Sex. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (f) Birth date. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (g) Social security number. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> 2. Information on the industrial or occupational history of the individual with the cancers, to the extent such information is available from the same record. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Administrative information, including at a minimum: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=14 g=1 f=1 --> (a) Date of diagnosis. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Date of admission. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c) Source of information. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> 4. Pathological data characterizing the cancer, including at a minimum: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=14 g=1 f=1 --> (a) Primary site. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Morphology type, behavior, and grade. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c) Sequence number. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (d) Laterality. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (e) Diagnostic confirmation. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (f) Stage of disease (pursuant to Summary Staging Guide). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (g) Date and type of first course of definitive treatment when available in the medical record. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (h) Date of death. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (i) Underlying cause of death. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. CDC Activities <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Convene a meeting of the funded States for information sharing, problem solving, and training at least annually. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Provide funded States with ongoing consultation for effective program planning and management, including, but not limited to, assistance in the development of model legislation for statewide cancer registries, assistance in establishing a computerized reporting and data processing system, and assistance in monitoring completeness, timeliness, and quality of data. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Collaborate in establishing or endorsing program requirements for completeness, timeliness, and accuracy of data, and monitor to assure compliance with program requirements. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. Collaborate in reporting of cancer rates and other components of an annual report on cancer occurrence in the State. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. Conduct site visits to assess program progress and mutually resolve problems, as needed. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            